NCT03189706 2025-07-02
Study of Chemoimmunotherapy for High-Risk Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
1 trialsPhase EARLY_PHASE1 × Active not recruiting × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all